BHLHE22
Basic information
Region (hg38): 8:64580364-64583627
Previous symbols: [ "TNRC20", "BHLHB5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BHLHE22 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 31 | 32 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 31 | 3 | 0 |
Variants in BHLHE22
This is a list of pathogenic ClinVar variants found in the BHLHE22 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-64580797-C-A | not specified | Uncertain significance (Apr 08, 2022) | ||
8-64580824-G-A | not specified | Uncertain significance (Mar 31, 2024) | ||
8-64580827-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
8-64580828-G-A | not specified | Uncertain significance (Dec 14, 2022) | ||
8-64580891-C-G | not specified | Uncertain significance (Sep 22, 2023) | ||
8-64580986-G-C | not specified | Uncertain significance (May 09, 2023) | ||
8-64581023-C-G | not specified | Uncertain significance (Aug 16, 2021) | ||
8-64581076-G-A | not specified | Uncertain significance (Mar 19, 2024) | ||
8-64581077-G-A | not specified | Uncertain significance (Oct 04, 2022) | ||
8-64581079-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
8-64581095-G-C | not specified | Uncertain significance (Dec 18, 2023) | ||
8-64581115-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
8-64581174-G-C | not specified | Uncertain significance (Apr 07, 2023) | ||
8-64581196-G-C | not specified | Uncertain significance (Mar 21, 2023) | ||
8-64581304-G-C | not specified | Uncertain significance (Oct 25, 2023) | ||
8-64581346-A-G | not specified | Uncertain significance (Dec 11, 2023) | ||
8-64581386-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
8-64581394-G-T | not specified | Uncertain significance (Jun 30, 2023) | ||
8-64581445-A-G | not specified | Likely benign (Apr 17, 2024) | ||
8-64581450-T-C | Likely benign (Dec 20, 2017) | |||
8-64581450-T-TAGCGGC | not specified | Likely benign (Jun 19, 2015) | ||
8-64581454-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
8-64581460-G-A | not specified | Uncertain significance (Aug 05, 2023) | ||
8-64581461-G-C | not specified | Uncertain significance (Feb 14, 2023) | ||
8-64581463-G-A | not specified | Uncertain significance (Oct 06, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BHLHE22 | protein_coding | protein_coding | ENST00000321870 | 1 | 3368 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.800 | 0.195 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.31 | 123 | 171 | 0.718 | 0.00000793 | 2323 |
Missense in Polyphen | 20 | 56.008 | 0.35709 | 698 | ||
Synonymous | -1.44 | 98 | 81.5 | 1.20 | 0.00000407 | 857 |
Loss of Function | 2.14 | 0 | 5.32 | 0.00 | 2.28e-7 | 72 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits DNA binding of TCF3/E47 homodimers and TCF3 (E47)/NEUROD1 heterodimers and acts as a strong repressor of Neurod1 and Myod-responsive genes, probably by heterodimerization with class a basic helix-loop-helix factors. Despite the presence of an intact basic domain, does not bind to DNA (By similarity). In the brain, may function as an area-specific transcription factor that regulates the postmitotic acquisition of area identities and elucidate the genetic hierarchy between progenitors and postmitotic neurons driving neocortical arealization. May be required for the survival of a specific population of inhibitory neurons in the superficial laminae of the spinal chord dorsal horn that may regulate pruritis. Seems to play a crucial role in the retinogenesis, in the specification of amacrine and bipolar subtypes. Forms with PRDM8 a transcriptional repressor complex controlling genes involved in neural development and neuronal differentiation. {ECO:0000250|UniProtKB:Q8C6A8}.;
Recessive Scores
- pRec
- 0.193
Haploinsufficiency Scores
- pHI
- 0.837
- hipred
- N
- hipred_score
- 0.464
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0909
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bhlhe22
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); cellular phenotype; vision/eye phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype;
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;neurogenesis
- Cellular component
- nucleus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protein dimerization activity